Calls Purchased on Questcor Pharmaceuticals

Shares of Questcor Pharmaceuticals QCOR are higher on the session by 20.00%, currently trading at $31.20. The stock has been moving largely higher over the past five months and is currently trading above the 200-day moving average. Options traders are buying calls on the name today. A short while ago the August 2011 $29.00 call traded 750 times on open interest of 1,317 contracts. Overall call volume is now running at 3.74x the daily average with 72% of all calls traded being purchases on the offer. Questcor Pharmaceuticals, Inc. is a biopharmaceutical company. Questcor primary product is H.P. Acthar Gel, an injectable drug that is approved by the United States Food and Drug Administration.